Chalcone Derivatives in Pharmacological Applications

Chalcone derivatives, characterised by an α,β-unsaturated ketone bridge between two aromatic rings, represent a versatile scaffold in medicinal chemistry. Their straightforward synthesis and amenability to structural modification have yielded a broad array of compounds with diverse biological activities. In anticancer research, chalcones disrupt cell cycle progression, induce apoptosis and modulate autophagy. In anti-inflammatory applications they inhibit key signalling pathways such as NF-κB, while antimicrobial and antioxidant activities arise from interactions with enzymes and reactive oxygen species. Hybridisation with heterocycles, pro-drug design and computer-assisted optimisation have improved potency, selectivity and pharmacokinetic profiles. Global efforts focus on combination regimens to enhance efficacy and overcome resistance, dietary supplementation to address chronic conditions and lead-optimisation campaigns to advance chalcone-based candidates towards clinical evaluation.

Research from Nature Portfolio

Seven novel chalcone derivatives were prepared via condensation of substituted benzaldehydes and acetophenone analogues, with full spectral characterisation undertaken. In silico docking against bacterial target proteins demonstrated strong binding affinities, especially for two derivatives. In vitro assays revealed potent inhibition of Staphylococcus aureus and Bacillus subtilis at low micromolar concentrations, moderate activity against Salmonella typhi, Escherichia coli and Aspergillus niger, and negligible effects on Pseudomonas aeruginosa. Antioxidant capacity, evaluated against a standard chelating agent, showed superior performance by three compounds at high concentrations. Drug-likeness and absorption/distribution/metabolism/excretion profiling identified a lead-like molecule suitable for further development.

Chalcone Derivatives in Pharmacological Applications publication trend

The graph below shows the total number of articles in chalcone derivatives in pharmacological applications across all publications each year (not limited to Nature Index journals).

Technical terms

Chalcone: A molecule featuring two aromatic rings joined by an α,β-unsaturated carbonyl, serving as a precursor to many flavonoids and a scaffold for drug design.

Claisen–Schmidt condensation: A base-catalysed reaction forming α,β-unsaturated ketones by condensing an aldehyde with a ketone.

Minimum inhibitory concentration (MIC): The lowest concentration of a compound that prevents visible growth of a microorganism in vitro.

Reactive oxygen species (ROS): Chemically reactive molecules containing oxygen, such as peroxides, which can induce oxidative stress or signal transduction.

Apoptosis: Programmed cell death involving a regulated cascade of molecular events leading to organised cellular dismantling.

References

1. A Combination of Cardamonin and Doxorubicin Selectively Affect Cell Viability of Melanoma Cells: An In Vitro Study. Antioxidants (2024).
2. Pharmacological Properties of Chalcones: A Review of Preclinical Including Molecular Mechanisms and Clinical Evidence. Frontiers in Pharmacology (2021).
3. New chalcone derivatives as potential antimicrobial and antioxidant agent. Scientific Reports (2021).